Edesa Biotech, Inc.EDSANASDAQ
Loading
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P36
Within normal range
Average
2058.81%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 100.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 100.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | -100.00% |
| Q3 2020 | -99.55% |
| Q2 2020 | -0.48% |
| Q1 2020 | 2.52% |
| Q4 2019 | -73.73% |
| Q3 2019 | 81974.00% |
| Q2 2019 | -99.58% |
| Q1 2019 | 122.04% |
| Q4 2018 | -2.26% |
| Q3 2018 | -25.73% |
| Q2 2018 | 14.05% |
| Q1 2018 | 212.65% |
| Q4 2017 | 611.35% |
| Q3 2017 | -85.97% |
| Q2 2017 | -67.42% |
| Q1 2017 | -55.58% |
| Q4 2016 | -48.62% |
| Q3 2016 | 52.47% |
| Q2 2016 | -44.51% |
| Q1 2016 | -33.15% |